Mibelas 24 fe and Headache - a phase IV clinical study of FDA data

Summary:

Headache is reported as a side effect among people who take Mibelas 24 fe (ethinyl estradiol; norethindrone acetate), especially for people who are female, 20-29 old, have been taking the drug for < 1 month also take Korlym, and have Birth control.

The phase IV clinical study analyzes which people have Headache when taking Mibelas 24 fe. It is created by eHealthMe based on reports of 184 people who have side effects when taking Mibelas 24 fe from the FDA, and is updated regularly.

What is Mibelas 24 fe?

Mibelas 24 fe has active ingredients of ethinyl estradiol; norethindrone acetate. eHealthMe is studying from 185 Mibelas 24 fe users. Check the latest studies of Mibelas 24 fe.

What is Headache?

Headache (pain in head) is found to be associated with 3,753 drugs and 5,772 conditions by eHealthMe. Check the latest studies of Headache.

On May, 06, 2026

184 people reported to have side effects when taking Mibelas 24 fe.
Among them, 22 people (11.96%) have Headache.

Among these 22 people:

How long have people been on Mibelas 24 fe when they have Headache? *

What is the gender of people who have Headache when taking Mibelas 24 fe? *

female: 100 %
male: 0.0 %

What is the age of people who have Headache when taking Mibelas 24 fe? *

What are other drugs people take besides Mibelas 24 fe? *

What are other side effects people have besides Headache? *

Vaginal Bleeding Between Periods: 7 people, 31.82%
Nausea (feeling of having an urge to vomit): 7 people, 31.82%
Mood Swings (an extreme or rapid change in mood): 6 people, 27.27%
Muscle Spasms (muscle contraction): 5 people, 22.73%
Dizziness: 5 people, 22.73%
Menstruation Irregular: 4 people, 18.18%
Visual Impairment: 3 people, 13.64%
Nausea And Vomiting: 3 people, 13.64%
Migraine (headache): 2 people, 9.09%
High Blood Pressure: 2 people, 9.09%

What are the existing conditions these people have? *

Birth Control: 12 people, 54.55%
Premenstrual Dysphoric Disorder: 3 people, 13.64%
Depression: 2 people, 9.09%
Cushing's Syndrome (obesity, a rounded face, increased fat): 2 people, 9.09%
Polycystic Ovary Disease (cysts in the ovaries that occurs when the follicle stops developing): 1 person, 4.55%
Heavy Or Prolong Menstrual Bleeding: 1 person, 4.55%
Dysmenorrhea (painful menstruation): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Mibelas 24 fe and have Headache?

- Check whether Headache is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mibelas 24 fe:

Mibelas 24 fe (185 reports)

Headache treatments and more:

Headache (756,642 reports)

How severe was Headache and when was it recovered:

Headache in Mibelas 24 fe

Expand to all the drugs that have ingredients of ethinyl estradiol; norethindrone acetate:

Headache and drugs with ingredients of ethinyl estradiol; norethindrone acetate (1,278 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mibelas 24 fe:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Headache:

Headache (3,753 drugs)

Browse all the conditions that are associated with Headache:

Headache (5,772 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ethinyl estradiol; norethindrone acetate (the active ingredients of Mibelas 24 fe) and Mibelas 24 fe (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.